• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

哮喘患者合并疾病治疗中的安全考量

Safety considerations in treating concomitant diseases in patients with asthma.

作者信息

Hunt L W

机构信息

Mayo Clinic and Graduate School of Medicine, Rochester, Minnesota, USA.

出版信息

Drug Saf. 1998 May;18(5):357-68. doi: 10.2165/00002018-199818050-00005.

DOI:10.2165/00002018-199818050-00005
PMID:9589847
Abstract

The treatment for asthma usually involves a combination of drugs used for bronchodilation and to treat underlying airway inflammation. When asthma is severe, the regimen used to treat asthma can become quite complicated, often using as many as 3 or 4 separate pharmacological agents. As patients with asthma get older, their medication regimen can become even more complex with the development of numerous other age-related diseases requiring their own list of medications. Diseases of the joints, diseases of the eye, cardiovascular disease, neurological disease and urological problems represent the most common conditions that patients develop, at times needing medications which might interfere with asthma management. Many of these diseases require the use of nonsteroidal anti-inflammatory agents, well known to provoke wheezing in patients with intrinsic asthma, and diseases of the eye and cardiovascular system frequently require use of beta-blockers which can cause or exacerbate asthma. Managing patients with asthma who have other diseases requires constant supervision of their medication usage and careful and cautious review of the entire list of medications at each presentation.

摘要

哮喘的治疗通常涉及用于支气管扩张和治疗潜在气道炎症的药物组合。当哮喘严重时,用于治疗哮喘的方案可能会变得相当复杂,常常使用多达3或4种不同的药物制剂。随着哮喘患者年龄的增长,由于出现了许多其他需要各自用药清单的与年龄相关的疾病,他们的用药方案可能会变得更加复杂。关节疾病、眼部疾病、心血管疾病、神经系统疾病和泌尿系统问题是患者最常出现的病症,有时需要使用可能干扰哮喘治疗的药物。其中许多疾病需要使用非甾体抗炎药,众所周知,这些药物会诱发内源性哮喘患者喘息,而眼部和心血管系统疾病常常需要使用可能导致或加重哮喘的β受体阻滞剂。治疗患有其他疾病的哮喘患者需要持续监督他们的用药情况,并在每次就诊时仔细谨慎地审查整个用药清单。

相似文献

1
Safety considerations in treating concomitant diseases in patients with asthma.哮喘患者合并疾病治疗中的安全考量
Drug Saf. 1998 May;18(5):357-68. doi: 10.2165/00002018-199818050-00005.
2
[Beta blockers in asthma and COPD--a therapeutic dilemma?].[β受体阻滞剂在哮喘和慢性阻塞性肺疾病中的应用——一个治疗难题?]
Pneumologie. 2001 Feb;55(2):53-6. doi: 10.1055/s-2001-11289.
3
Medications as asthma triggers.药物作为哮喘的触发因素。
Immunol Allergy Clin North Am. 2005 Feb;25(1):169-90. doi: 10.1016/j.iac.2004.09.009.
4
[Beta-blockers and statins in the context of asthma].[哮喘背景下的β受体阻滞剂和他汀类药物]
Postepy Hig Med Dosw (Online). 2009 Dec 16;63:634-42.
5
Overcoming gaps in the management of asthma in older patients: new insights.克服老年患者哮喘管理中的差距:新见解
Drugs Aging. 2005;22(12):1029-59. doi: 10.2165/00002512-200522120-00004.
6
Cardiovascular drug therapy in the elderly.老年人的心血管药物治疗
Cardiol Rev. 2007 Jul-Aug;15(4):195-215. doi: 10.1097/CRD.0b013e3180301b69.
7
[Limitations of current treatment of asthma: possibilities for new treatment forms].[哮喘当前治疗的局限性:新治疗形式的可能性]
Med Klin (Munich). 1996 May 15;91(5):302-7.
8
Think the impossible: beta-blockers for treating asthma.想象不可能之事:用β受体阻滞剂治疗哮喘。
Clin Sci (Lond). 2009 Oct 12;118(2):115-20. doi: 10.1042/CS20090398.
9
Q: Can patients with COPD or asthma take a beta-blocker?
Cleve Clin J Med. 2010 Aug;77(8):498-9. doi: 10.3949/ccjm.77a.09133.
10
Use and costs of anti-secretory and cardiovascular co-medication in osteoarthritis patients treated with selective or non-selective NSAIDS.使用选择性或非选择性非甾体抗炎药治疗的骨关节炎患者中抗分泌药与心血管联合用药的使用情况及成本
Pharm World Sci. 2006 Oct;28(5):309-17. doi: 10.1007/s11096-006-9050-6. Epub 2006 Nov 17.

本文引用的文献

1
EFFECT OF A BETA-ADRENERGIC-BLOCKING AGENT, PROPRANOLOL, ON ASTHMATICS.β-肾上腺素能阻滞剂普萘洛尔对哮喘患者的影响。
Lancet. 1964 Nov 21;2(7369):1101-2. doi: 10.1016/s0140-6736(64)92617-0.
2
Angiotensin-converting enzyme (ACE) inhibitors and angio-oedema.血管紧张素转换酶(ACE)抑制剂与血管性水肿
Br J Dermatol. 1997 Feb;136(2):153-8.
3
Exacerbation of asthma by topical diclofenac.局部用双氯芬酸加重哮喘
Arch Ophthalmol. 1997 Feb;115(2):294-5. doi: 10.1001/archopht.1997.01100150296037.
4
Epidemiological study of angioedema and ACE inhibitors.血管性水肿与血管紧张素转换酶抑制剂的流行病学研究。
Aust N Z J Med. 1996 Dec;26(6):777-82. doi: 10.1111/j.1445-5994.1996.tb00624.x.
5
Adverse CNS-effects of beta-adrenoceptor blockers.
Pharmacopsychiatry. 1996 Nov;29(6):201-11. doi: 10.1055/s-2007-979572.
6
Ketorolac-induced bronchospasm in an aspirin-intolerant patient.酮咯酸在一名阿司匹林不耐受患者中诱发支气管痉挛。
Anesth Prog. 1994;41(4):102-7.
7
An overview of the diagnosis and pharmacologic treatment of migraine.
Mayo Clin Proc. 1996 Nov;71(11):1055-66. doi: 10.4065/71.11.1055.
8
Angiooedema and urticaria with angiotensin converting enzyme inhibitors.
Eur J Clin Pharmacol. 1996;51(2):123-6. doi: 10.1007/s002280050171.
9
Visceral angioedema related to treatment with an ACE inhibitor.与使用血管紧张素转换酶抑制剂治疗相关的内脏性血管性水肿。
Med J Aust. 1996 Sep 16;165(6):319-21. doi: 10.5694/j.1326-5377.1996.tb124991.x.
10
Problem drugs for the patient with asthma.
Compr Ther. 1996 Jun;22(6):339-44.